The role of G protein-coupled receptors in the pathology of Alzheimer's disease

Alzheimer's disease: the amyloid cascade hypothesis

Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · see citing works

International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126 · see citing works

The cholinergic hypothesis of geriatric memory dysfunction

Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545 · see citing works

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627 · see citing works

SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE

DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565 · see citing works

Diffusible, nonfibrillar ligands derived from Aβ _1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · see citing works

PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS

Conn, P. J., & Pin, J. (1997) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.205 · Cited by 3,083 · see citing works

The molecular pathology of Alzheimer's disease

Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708 · see citing works

International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors

Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585 · see citing works

P <scp>ROTOFIBRILS</scp> , P <scp>ORES</scp> , F <scp>IBRILS, AND</scp> N <scp>EURODEGENERATION</scp> : Separating the Responsible Protein Aggregates from The Innocent Bystanders

Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650 · see citing works

Somatostatin and Its Receptor Family

Patel, Y. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0183 · Cited by 1,648 · see citing works

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.

Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299 · see citing works

APRIORITY

Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290 · see citing works

Role for Neuronally Derived Fractalkine in Mediating Interactions between Neurons and CX3CR1-Expressing Microglia

Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176 · see citing works

Pharmacological agents acting at subtypes of metabotropic glutamate receptors

Schoepp, D. D., Jane, D. E., & Monn, J. A. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00092-1 · Cited by 1,061 · see citing works

Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology

Radde, R., Bolmont, T., Kaeser, S. A., Coomaraswamy, J., Lindau, D., Stoltze, L., Calhoun, M. E., Jäggi, F., Wolburg, H., Gengler, S., et al. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400784 · Cited by 986 · see citing works

Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex

De Strooper, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00205-8 · Cited by 965 · see citing works

Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies

Levey, A. I., Kitt, C. A., Wf, S., Price, D., & Brann, M. R. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-10-03218.1991 · Cited by 920 · see citing works

Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915 · see citing works

Release of Alzheimer Amyloid Precursor Derivatives Stimulated by Activation of Muscarinic Acetylcholine Receptors

Nitsch, R. M., Slack, B. E., Wurtman, R. J., & Growdon, J. H. (1992) · Science · doi:10.1126/science.1411529 · Cited by 898 · see citing works

Metabolic Regulation of Brain Aβ by Neprilysin

Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N., Gerard, C., Hama, E., Lee, H., & Saido, T. (2001) · Science · doi:10.1126/science.1059946 · Cited by 894 · see citing works

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

Davies, P., Katzman, R., & Terry, R. D. (1980) · Nature · doi:10.1038/288279a0 · Cited by 882 · see citing works

Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor

Ichiki, T., Labosky, P. A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., Niimura, F., Ichikawa, I., Hogan, B. L. M., & lnagami, T. (1995) · Nature · doi:10.1038/377748a0 · Cited by 855 · see citing works

Cellular and Synaptic Adaptations Mediating Opioid Dependence

Williams, J. T., Christie, M. J., & Manzoni, O. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.299 · Cited by 852 · see citing works

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., et al. (2003) · Nature Medicine · doi:10.1038/nm919 · Cited by 851 · see citing works

The secretases: enzymes with therapeutic potential in Alzheimer disease

De Strooper, B., Vassar, R., & Golde, T. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.218 · Cited by 799 · see citing works

AGTR2 Mutations in X-Linked Mental Retardation

Vervoort, V. S., Beachem, M. A., Edwards, P. S., Ladd, S., Miller, K. E., de Mollerat, X., Clarkson, K., DuPont, B. R., Schwartz, C. E., Stevenson, R. E., et al. (2002) · Science · doi:10.1126/science.1072191 · Cited by 722 · see citing works

Unveiling the Functions of Presynaptic Metabotropic Glutamate Receptors in the Central Nervous System

Schoepp, D. D. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29296-x · Cited by 693 · see citing works

Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development

Wess, J., Eglen, R. M., & Gautam, D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2379 · Cited by 637 · see citing works

Microglial response to amyloid plaques in APPsw transgenic mice.

Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B. T., Saido, T. C., Hsiao, K., & Cole, G. M. (1998) · Europe PMC (PubMed Central) · Cited by 592 · see citing works

The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic Potential

Vassar, R., Kovacs, D. M., Yan, R., & Wong, P. C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3657-09.2009 · Cited by 577 · see citing works

Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease

Fuhrmann, M., Bittner, T., Jung, C. K. E., Burgold, S., Page, R. M., Mitteregger, G., Haass, C., LaFerla, F. M., Kretzschmar, H., & Herms, J. (2010) · Nature Neuroscience · doi:10.1038/nn.2511 · Cited by 562 · see citing works

Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor.

Buxbaum, J. D., Oishi, M., Chen, H. I., Pinkas‐Kramarski, R., JAFFE, E. A., Gandy, S., & Greengard, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10075 · Cited by 558 · see citing works

Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice

Anagnostaras, S., Murphy, G. G., Hamilton, S. E., Mitchell, S. L., Rahnama, N. P., Nathanson, N. M., & Silva, A. J. (2002) · Nature Neuroscience · doi:10.1038/nn992 · Cited by 543 · see citing works

Brain Insulin Receptors and Spatial Memory

Zhao, W., Chen, H., Xu, H., Moore, E., Meiri, N., Quon, M. J., & Alkon, D. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34893 · Cited by 535 · see citing works

Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes

Takeda, S., Sato, N., Uchio‐Yamada, K., Sawada, K., Kunieda, T., Takeuchi, D., Kurinami, H., Shinohara, M., Rakugi, H., & Morishita, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000645107 · Cited by 506 · see citing works

Insulin and the insulin receptor in experimental models of learning and memory

Zhao, W., Chen, H., Quon, M. J., & Alkon, D. L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.045 · Cited by 503 · see citing works

Chemokine Expression by Glial Cells Directs Leukocytes to Sites of Axonal Injury in the CNS

Babcock, A. A., Kuziel, W. A., Rivest, S., & Owens, T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07922.2003 · Cited by 472 · see citing works

β-Amyloid Activates the Mitogen-Activated Protein Kinase Cascade via Hippocampal α7 Nicotinic Acetylcholine Receptors:<i>In Vitro</i>and<i>In Vivo</i>Mechanisms Related to Alzheimer's Disease

Dineley, K. T., Westerman, M., Bui, D., Bell, K., Ashe, K. H., & Sweatt, J. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04125.2001 · Cited by 462 · see citing works

The Angiotensin II AT2 Receptor Is an AT1Receptor Antagonist

AbdAlla, S., Lother, H., Abdel-Tawab, A. M., & Quitterer, U. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105253200 · Cited by 462 · see citing works

Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production

Arendash, G. W., Schleif, W. S., Rezai-Zadeh, K. P., Jackson, E. K., Zacharia, L. C., Cracchiolo, J. R., Shippy, D. C., & Tan, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.021 · Cited by 459 · see citing works

Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process

De Strooper, B. (2010) · Physiological Reviews · doi:10.1152/physrev.00023.2009 · Cited by 455 · see citing works

Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation.

Buxbaum, J. D., Gandy, S., Cicchetti, P., Ehrlich, M. E., Czernik, A. J., Fracasso, R. P., Ramabhadran, T. V., Unterbeck, A., & Greengard, P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.6003 · Cited by 450 · see citing works

M1 Receptors Play a Central Role in Modulating AD-like Pathology in Transgenic Mice

Caccamo, A., Oddo, S., Billings, L. M., Green, K. N., Martinez-Coria, H., Fisher, A., & LaFerla, F. M. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.020 · Cited by 417 · see citing works

Increased Activity‐Regulating and Neuroprotective Efficacy of α‐Secretase‐Derived Secreted Amyloid Precursor Protein Conferred by a C‐Terminal Heparin‐Binding Domain

Furukawa, K., Sopher, B. L., Rydel, R. E., Begley, J. G., Pham, D. G., Martin, G. M., Fox, M., & Mattson, M. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67051882.x · Cited by 414 · see citing works

A Novel Rat Serotonin (5-HT6) Receptor: Molecular Cloning, Localization and Stimulation of cAMP Accumulation

Ruat, M., Traiffort, É., Arrang, J., Tardivel‐Lacombe, J., Díaz, J., Leurs, R., & Schwartz, J. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1619 · Cited by 413 · see citing works

Place Learning and Hippocampal Synaptic Plasticity in Streptozotocin-Induced Diabetic Rats

Biessels, G. J., Kamal, A., Ramakers, G. M. J., Urban, I. J. A., Spruijt, B. M., Erkelens, D. W., & Gispen, W. H. (1996) · Diabetes · doi:10.2337/diab.45.9.1259 · Cited by 413 · see citing works

Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells

Buteau, J., Roduit, R., Susini, S., & Prentki, M. (1999) · Diabetologia · doi:10.1007/s001250051238 · Cited by 413 · see citing works

Formation and maintenance of Alzheimer's disease β-amyloid plaques in the absence of microglia

Grathwohl, S. A., Kälin, R. E., Bolmont, T., Prokop, S., Winkelmann, G., Kaeser, S. A., Odenthal, J., Radde, R., Eldh, T., Gandy, S., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2432 · Cited by 401 · see citing works

Activation of protein kinase C inhibits cellular production of the amyloid beta-protein.

Hung, A. Y., Haass, C., Nitsch, R. M., Qiu, W. Q., Citron, M., Wurtman, R. J., Growdon, J. H., & Selkoe, D. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49409-x · Cited by 399 · see citing works

Tumor Necrosis Factor-α, Interleukin-1β, and Interferon-γ Stimulate γ-Secretase-mediated Cleavage of Amyloid Precursor Protein through a JNK-dependent MAPK Pathway

Liao, Y.-F., Wang, B.-J., Cheng, H.-T., Kuo, L.-H., & Wolfe, M. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402034200 · Cited by 389 · see citing works

A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth

Small, D. H., Nurcombe, V., Reed, G., Clarris, H. J., Moir, R. D., Beyreuther, K. T., & Masters, C. L. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-04-02117.1994 · Cited by 389 · see citing works

Expression of chemokine receptors by subsets of neurons in the central nervous system

Horuk, R., Martin, A. W., Wang, Z., Schweitzer, L., Gerassimides, A., Guo, H.-D., Lu, Z., Hesselgesser, J., Perez, H. D., Kim, J., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2882 · Cited by 385 · see citing works

Cloning, Characterization, and Chromosomal Localization of a Human 5‐HT6 Serotonin Receptor

Kohen, R., Metcalf, M. A., Khan, N. A., Druck, T., Huebner, K., Lachowicz, J. E., Meltzer, H. Y., Sibley, D. R., Roth, B. L., & Hamblin, M. W. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66010047.x · Cited by 377 · see citing works

Caffeine and adenosine A2a receptor antagonists prevent β-amyloid (25–35)-induced cognitive deficits in mice

Dall'Igna, O. P. P., Neto, P. F., Gomes, M. W. S., Souza, D. O., Cunha, R. A., & Lara, D. R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.008 · Cited by 372 · see citing works

Presynaptic glutamate receptors: physiological functions and mechanisms of action

Pinheiro, P. S., & Mulle, C. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2379 · Cited by 368 · see citing works

Common pathological processes in Alzheimer disease and type 2 diabetes: A review

Li, L., & Hölscher, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.001 · Cited by 367 · see citing works

Somatostatin regulates brain amyloid β peptide Aβ42 through modulation of proteolytic degradation

Saito, T., Iwata, N., Tsubuki, S., Takaki, Y., Takano, J., Huang, S.-M., Suemoto, T., Higuchi, M., & Saido, T. C. (2005) · Nature Medicine · doi:10.1038/nm1206 · Cited by 361 · see citing works

Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer disease

Levey, A. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13541 · Cited by 359 · see citing works

Aβ40 Inhibits Amyloid Deposition<i>In Vivo</i>

Kim, J., Onstead, L., Randle, S., Price, R., Smithson, L., Zwizinski, C., Dickson, D. W., Golde, T., & McGowan, E. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4849-06.2007 · Cited by 359 · cited 1× · see citing works

Adenosine A2AReceptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by β-Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway

Canas, P. M., Porciúncula, L. O., Cunha, G. M. A., Silva, C. G., Machado, N. J., Oliveira, J. M. A., Oliveira, C. R., & Cunha, R. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3728-09.2009 · Cited by 358 · see citing works

Can Alzheimer disease be prevented by amyloid-β immunotherapy?

Lemere, C. A., & Masliah, E. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.219 · Cited by 351 · see citing works

Fractalkine Cleavage from Neuronal Membranes Represents an Acute Event in the Inflammatory Response to Excitotoxic Brain Damage

Chapman, G. A., Moores, K., Harrison, D. C., Campbell, C. A., Stewart, B. R., & Strijbos, P. J. L. M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-j0004.2000 · Cited by 349 · see citing works

Glucagon‐like peptide‐1 decreases endogenous amyloid‐β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron

Perry, T., Lahiri, D. K., Sambamurti, K., Chen, D., Mattson, M. P., Egan, J. M., & Greig, N. H. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10611 · Cited by 347 · see citing works

Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein.

Caporaso, G. L., Gandy, S., Buxbaum, J. D., Ramabhadran, T. V., & Greengard, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3055 · Cited by 338 · see citing works

Insulin-like growth factor I protects and rescues hippocampal neurons against β-amyloid- and human amylin-induced toxicity

Doré, S., Kar, S., & Quirion, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4772 · Cited by 325 · see citing works

Characterization of Central Inhibitory Muscarinic Autoreceptors by the Use of Muscarinic Acetylcholine Receptor Knock-Out Mice

Zhang, W., Basile, A. S., Gomeza, J., Volpicelli‐Daley, L. A., Levey, A. I., & Wess, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01709.2002 · Cited by 314 · see citing works

Presenilin-1, Nicastrin, Amyloid Precursor Protein, and γ-Secretase Activity Are Co-localized in the Lysosomal Membrane

Pasternak, S., Bagshaw, R. D., Guiral, M., Zhang, S., Ackerley, C. A., Pak, B. J., Callahan, J. W., & Mahuran, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304009200 · Cited by 314 · see citing works

β-Amyloid 1–42 Peptide Directly Modulates Nicotinic Receptors in the Rat Hippocampal Slice

Pettit, D. L., Shao, Z., & Yakel, J. L. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-01-j0003.2001 · Cited by 291 · see citing works

Therapy insight, type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease

Haan, M. N. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0124 · Cited by 284 · see citing works

The role of Aβ42 in Alzheimer's disease

Younkin, S. G. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80035-1 · Cited by 282 · see citing works

Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease

Abbas, T. F., Faivre, É., & Hölscher, C. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.035 · Cited by 282 · see citing works

The neurobiology of somatostatin.

Epelbaum, J., Dournaud, P., Fodor, M., et al. (1994) · PubMed · Cited by 272 · see citing works

Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide.

Buxbaum, J. D., Koo, E. H., & Greengard, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9195 · Cited by 272 · see citing works

The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease

Carro, E., & Torres‐Alemán, I. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.050 · Cited by 262 · see citing works

5-HT6 Receptor Antagonists as Novel Cognitive Enhancing Agents for Alzheimer's Disease

Upton, N., Chuang, T. T., Hunter, A. J., & Virley, D. J. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.008 · Cited by 257 · see citing works

Neuroprotection by caffeine and adenosine A 2A receptor blockade of β ‐amyloid neurotoxicity

Dall'lgna, O. P., Porciúncula, L. O., Souza, D. O., Cunha, R. A., & Lara, D. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705185 · Cited by 255 · see citing works

Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease

Souza, E. B. D., Whitehouse, P. J., Kuhar, M. J., Price, D. L., & Vale, W. (1986) · Nature · doi:10.1038/319593a0 · Cited by 255 · see citing works

Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease

Behan, D., Heinrichs, S., Troncoso, J., Liu, X.-J., Kawas, C., Ling, N., & de Souza, E. D. (1995) · Nature · doi:10.1038/378284a0 · Cited by 248 · see citing works

Novel Selective Allosteric Activator of the M1Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats

Jones, C. K., Brady, A. E., Davis, A. A., Xiang, Z., Bubser, M., Tantawy, M. N., Kane, A. S., Bridges, T. M., Kennedy, J. P., Bradley, S. R., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1850-08.2008 · Cited by 248 · see citing works

Identification of monocyte chemoattractant protein‐1 in senile plaques and reactive microglia of Alzheimer's disease

ISHIZUKA, K., KIMURA, T., IGATA‐YI, R., KATSURAGI, S., TAKAMATSU, J., & MIYAKAWA, T. (1997) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1997.tb02375.x · Cited by 245 · see citing works

Activation of β2-adrenergic receptor stimulates γ-secretase activity and accelerates amyloid plaque formation

Ni, Y., Zhao, X., Bao, G., Zou, L., Teng, L., Wang, Z., Song, M., Xiong, J., Bai, Y., & Pei, G. (2006) · Nature Medicine · doi:10.1038/nm1485 · Cited by 237 · see citing works

5-HT6 receptors: a novel target for cognitive enhancement

Mitchell, E. S., & Neumaier, J. F. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.05.001 · Cited by 234 · see citing works

Differential Regulation of Molecular Subtypes of Muscarinic Receptors in Alzheimer's Disease

Flynn, D. D., Ferrari-Dileo, G., Mash, D. C., & Levey, A. I. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041888.x · Cited by 234 · see citing works

Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C.

Wheeler, M. B., Lu, M., Dillon, J. S., Leng, X. H., Chen, C., & Boyd, A. E. (1993) · Endocrinology · doi:10.1210/endo.133.1.8391428 · Cited by 225 · see citing works

Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion

Nitsch, R. M., Deng, M., Growdon, J. H., & Wurtman, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4188 · Cited by 219 · see citing works

Truncated β-amyloid peptide channels provide an alternative mechanism for Alzheimer’s Disease and Down syndrome

Jang, H., Arce, F. T., Ramachandran, S., Capone, R. F., Azimova, R., Kagan, B. L., Nussinov, R., & Lal, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914251107 · Cited by 216 · see citing works

Pancreatic Glucagon-Like Peptide-1 Receptor Couples to Multiple G Proteins and Activates Mitogen-Activated Protein Kinase Pathways in Chinese Hamster Ovary Cells

Montrose‐Rafizadeh, C., Avdonin, P. V., Garant, M. J., Rodgers, B. D., Kole, S., Yang, H. M., Levine, M. A., Schwindinger, W. F., & Bernier, M. (1999) · Endocrinology · doi:10.1210/endo.140.3.6550 · Cited by 216 · see citing works

Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors

Uhlenbrock, K., Gassenhuber, J., & Kostenis, E. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(02)00041-4 · Cited by 215 · see citing works

Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1×APP transgenic model of Alzheimer's disease

Ramos, B., Baglietto‐Vargas, D., del Río, J. C., Moreno‐González, I., Santa‐María, C., Jiménez, S., Caballero, C., Lopez-Tellez, J. F., Khan, Z. U., Ruano, D., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.022 · Cited by 213 · see citing works

Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease

Oddo, S., Caccamo, A., Green, K. N., Liang, K., Tran, L., Chen, Y., Leslie, F. M., & LaFerla, F. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408500102 · Cited by 211 · see citing works

5‐Hydroxytryptamine (5‐HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases

Reynolds, G. P., Mason, S., Meldrum, A., Keczer, S. D., Parties, H., Eglen, R. M., & Wong, E. H. F. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13303.x · Cited by 208 · see citing works

5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease

Holmes, C. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.9.1507 · Cited by 205 · see citing works

Chronic nicotine treatment reduces β‐amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw)

Nordberg, A. K., Hellström‐Lindahl, E., Lee, M., Johnson, M. A., Mousavi, M. T., Hall, R., Perry, E. K., Bednar, I., & COURT, J. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00874.x · Cited by 204 · see citing works

Deletion of the 7 Nicotinic Acetylcholine Receptor Gene Improves Cognitive Deficits and Synaptic Pathology in a Mouse Model of Alzheimer's Disease

Dziewczapolski, G., Głogowski, M., Masliah, E., & Heinemann, S. F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6159-08.2009 · Cited by 197 · see citing works

Alzheimer's disease: Changes in hippocampal N-methyl-d-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors—an autoradiographic study

Jansen, K. L. R., Faull, R. L. M., Dragunow, M., & Synek, B. J. L. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90246-z · Cited by 197 · see citing works

The Orphan G Protein–Coupled Receptor 3 Modulates Amyloid-Beta Peptide Generation in Neurons

Thathiah, A., Spittaels, K., Hoffmann, M., Staes, M., Cohen, A., Horré, K., Vanbrabant, M., Coun, F., Baekelandt, V., Delacourte, A., et al. (2009) · Science · doi:10.1126/science.1160649 · Cited by 196 · see citing works

Levels of α- and β-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients

Sennvik, K., Fastbom, J., Blomberg, M. E., Wahlund, L., Winblad, B., & Benedikz, E. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00929-5 · Cited by 193 · see citing works

m1–m5 Muscarinic Receptor Distribution in Rat CNS by RT‐PCR and HPLC

Wei, J., Walton, E. A., Milici, A., & Buccafusco, J. J. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63030815.x · Cited by 191 · see citing works

Activation of a cAMP-regulated Ca2+-Signaling Pathway in Pancreatic β-Cells by the Insulinotropic Hormone Glucagon-like Peptide-1

Holz, G. G., Leech, C. A., & Habener, J. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.30.17749 · Cited by 188 · see citing works

Crosstalk between Rap1 and Rac regulates secretion of sAPPα

Maillet, M., Robert, S. J., Cacquevel, M., Gastineau, M., Vivien, D., Bertoglio, J. H., Zugaza, J. L., Fischmeister, R., & Lezoualc’h, F. (2003) · Nature Cell Biology · doi:10.1038/ncb1007 · Cited by 187 · see citing works

Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain

Joo, K. M., Chung, Y. H., Kim, M., Nam, R. H., Lee, B. L., Lee, K. H., & Ik, C. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20231 · Cited by 186 · see citing works

α7 Nicotinic Acetylcholine Receptors Mediate β-Amyloid Peptide-induced Tau Protein Phosphorylation

Wang, H.-Y., Li, W., Benedetti, N. J., & Lee, D. H. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212532200 · Cited by 185 · see citing works

Memantine Improves Spatial Learning in a Transgenic Mouse Model of Alzheimer’s Disease

Minkeviciene, R., Banerjee, P., & Tanila, H. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.071027 · Cited by 184 · see citing works

Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors.

Lee, R. K., Wurtman, R. J., Cox, A. J., & Nitsch, R. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.8083 · Cited by 179 · see citing works

A1 Adenosine Receptors Accumulate in Neurodegenerative Structures in Alzheimer's Disease and Mediate Both Amyloid Precursor Protein Processing and Tau Phosphorylation and Translocation

Angulo-Pueyo, E., Casadó, V., Mallol, J., Canela, E. I., Viñals, F., Ferrer, I., Lluís, C., & Franco, R. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00475.x · Cited by 179 · see citing works

Secreted form of β-amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices

Ishida, A., Furukawa, K., Keller, J. N., & Mattson, M. P. (1997) · Neuroreport · doi:10.1097/00001756-199707070-00009 · Cited by 178 · see citing works

RESEARCH ARTICLE: Up‐regulation of Adenosine Receptors in the Frontal Cortex in Alzheimer's Disease

Albasanz, J. L., Perez, S., Barrachina, M., Ferrer, I., & Martı́n, M. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00112.x · Cited by 177 · see citing works

Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase‐dependent pathway

Solano, D. C., Sironi, M., Bonfini, C., Solerte, S. B., Govoni, S. M., & Racchi, M. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.1015 · Cited by 175 · see citing works

5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex

Consolo, S., Arnaboldi, S., Giorgi, S., Russi, G., & Ladinsky, H. (1994) · Neuroreport · doi:10.1097/00001756-199406020-00018 · Cited by 174 · see citing works

Loss of brain 5-HT2receptors in Alzheimer's disease

Blin, J., Baron, J., Dubois, B., et al. (1993) · Brain · doi:10.1093/brain/116.3.497 · Cited by 172 · see citing works

Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations

Bissette, G. (1985) · JAMA · doi:10.1001/jama.254.21.3067 · Cited by 167 · see citing works

Subcellular Topography of Neuronal Aβ Peptide in APPxPS1 Transgenic Mice

Langui, D., Girardot, N., El Hachimi, K. H., Allinquant, B., Blanchard, V., Pradier, L., & Duyckaerts, C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63405-0 · Cited by 165 · see citing works

Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice

Tzavara, E. T., Bymaster, F. P., Felder, C. C., Wade, M. R., Gomeza, J., Wess, J., McKinzie, D. L., & Nomikos, G. G. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001270 · Cited by 163 · see citing works

Adrenergic Receptors in Aging and Alzheimer's Disease: Increased β2‐Receptors in Prefrontal Cortex and Hippocampus

Kalaria, R. N., Andorn, A. C., Tabaton, M., Whitehouse, P. J., Harik, S. I., & Unnerstall, J. R. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09242.x · Cited by 163 · see citing works

Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent

Higgins, G. A., Ballard, T. M., Kew, J. N. C., Richards, J. G., Kemp, J. A., Adam, G., Woltering, T. J., Nakanishi, S., & Mutel, V. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.018 · Cited by 158 · see citing works

Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology

Beeri, M. S., Schmeidler, J., Silverman, J. M., Gandy, S., Wysocki, M., Hannigan, C. M., Purohit, D. P., Lesser, G., Grossman, H. T., & Haroutunian, V. (2008) · Neurology · doi:10.1212/01.wnl.0000324925.95210.6d · Cited by 157 · see citing works

Regulated secretion of beta-amyloid precursor protein in rat brain

Farber, S., Nitsch, R. M., Schulz, J., & Wurtman, R. J. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07442.1995 · Cited by 155 · see citing works

GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid

Gault, V. A., & Hölscher, C. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.025 · Cited by 155 · see citing works

Amyloid-β-induced chemokine production in primary human macrophages and astrocytes

Smits, H. A., Rijsmus, A., van Loon, J. H., Wat, J. W. Y., Verhoef, J., Boven, L. A., & Nottet, H. S. L. M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00112-1 · Cited by 151 · see citing works

Neural Expression of G Protein-coupled Receptors GPR3, GPR6, and GPR12 Up-regulates Cyclic AMP Levels and Promotes Neurite Outgrowth

Tanaka, S., Ishii, K. J., Kasai, K., Yoon, S. O., & Saeki, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700911200 · Cited by 147 · see citing works

Activation of the extracellular signal‐regulated kinase 2 by metabotropic glutamate receptors

Ferraguti, F., Baldani‐Guerra, B., Corsi, M., Nakanishi, S., & Corti, C. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00626.x · Cited by 144 · see citing works

Association of the Serotonin Transporter and Receptor Gene Polymorphisms in Neuropsychiatric Symptoms in Alzheimer Disease

Assal, F., Alarcón, M., Solomon, E., Masterman, D. L., Geschwind, D. H., & Cummings, J. L. (2004) · Archives of Neurology · doi:10.1001/archneur.61.8.1249 · Cited by 142 · see citing works

Activation of m 1 Muscarinic Acetylcholine Receptor Regulates τ Phosphorylation in Transfected PC12 Cells

Sadot, E., Gurwitz, D., Barg, J., Behar, L., Ginzburg, I., & Fisher, A. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66020877.x · Cited by 139 · see citing works

Deletion of M ₁ Muscarinic Acetylcholine Receptors Increases Amyloid Pathology <i>In Vitro</i> and <i>In Vivo</i>

Davis, A. A., Fritz, J. J., Wess, J., Lah, J. J., & Levey, A. I. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6393-09.2010 · Cited by 137 · see citing works

Regulation of Amyloid Precursor Protein Catabolism Involves the Mitogen-Activated Protein Kinase Signal Transduction Pathway

Mills, J., Laurent Charest, D., Lam, F., Beyreuther, K., Ida, N., Pelech, S. L., & Reiner, P. B. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-24-09415.1997 · Cited by 134 · see citing works

The 5-HT6 Receptor Antagonist SB-271046 Reverses Scopolamine-Disrupted Consolidation of a Passive Avoidance Task and Ameliorates Spatial Task Deficits in Aged Rats

Foley, A., Murphy, K. J., Hirst, W. D., Gallagher, H. C., Hagan, J. J., Upton, N., Walsh, F. S., & Regan, C. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300332 · Cited by 133 · see citing works

Caffeine enhances acetylcholine release in the hippocampus in vivo by a selective interaction with adenosine A1 receptors.

Carter, A. J., O'Connor, W. T., Carter, M. J., & Ungerstedt, U. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09521-7 · Cited by 132 · see citing works

Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease.

Xia, M., Qin, S., McNamara, M. J., Mackay, C. R., & Hyman, B. T. (1997) · Europe PMC (PubMed Central) · Cited by 131 · see citing works

Regulated endocytosis of opioid receptors: cellular mechanisms and proposed roles in physiological adaptation to opiate drugs

von Zastrow, M., Svingos, A. L., Haberstock-Debic, H., & Evans, C. (2003) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(03)00069-2 · Cited by 127 · see citing works

Nicotine reduces Aβ in the brain and cerebral vessels of APPsw mice

Hellström‐Lindahl, E., COURT, J. A., Keverne, J., Svedberg, M. M., Lee, M., Marutle, A., Thomas, A. J., Perry, E. K., Bednar, I., & Nordberg, A. K. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03377.x · Cited by 127 · see citing works

Memantine lowers amyloid‐β peptide levels in neuronal cultures and in APP/PS1 transgenic mice

Alley, G. M., Bailey, J. A., Chen, D., Ray, B., Puli, L., Tanila, H., Banerjee, P., & Lahiri, D. K. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22172 · Cited by 124 · see citing works

Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's‐disease‐model transgenic mice shown as by micromagnetic resonance imaging

Scholtzova, H., Wadghiri, Y. Z., Douadi, M., Sigurdsson, E. M., Li, Y., Quartermain, D., Banerjee, P., & Wısnıewskı, T. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21713 · Cited by 119 · see citing works

The neuropeptide PACAP promotes ?‐secretase pathway for processing Alzheimer amyloid precursor protein

Kojro, E., Postina, R., Buro, C., Meiringer, C., Gehrig‐Burger, K., & Fahrenholz, F. (2006) · The FASEB Journal · doi:10.1096/fj.05-4812fje · Cited by 118 · see citing works

μ-, δ- and κ-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer’s disease patients

Mathieu-Kia, A.-M., Fan, L.-Q., Kreek, M. J., Simon, E. J., & Hiller, J. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03302-3 · Cited by 118 · see citing works

The Human Serotonin 5-HT4 Receptor Regulates Secretion of Non-amyloidogenic Precursor Protein

Robert, S. J., Zugaza, J. L., Fischmeister, R., Gardier, A. M., & Lezoualc’h, F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m109008200 · Cited by 118 · see citing works

Corticotropin-Releasing Hormone-Mediated Neuroprotection against Oxidative Stress Is Associated with the Increased Release of Non-amyloidogenic Amyloid β Precursor Protein and with the Suppression of Nuclear Factor-κB

Lezoualc’h, F., Engert, S., Berning, B., & Behl, C. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.1.0403 · Cited by 116 · see citing works

Activation of 5-HT4 receptors inhibits secretion of β-amyloid peptides and increases neuronal survival

Cho, S., & Hu, Y. F. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.07.021 · Cited by 114 · see citing works

Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients

Lorke, D. E., Lü, G., Cho, E. Y. P., & Yew, D. T. W. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-36 · Cited by 113 · see citing works

Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain

Giménez‐Llort, L., Schiffmann, S. N., Shmidt, T., Canela, L., Camón, L., Wassholm, M., Canals, M., Terasmaa, A., Fernández‐Teruel, A., Tobeña, A., et al. (2006) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2006.05.004 · Cited by 113 · see citing works

Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes

Albasanz, J. L., Dalfó, E., Ferrer, I., & Martı́n, M. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.001 · Cited by 111 · see citing works

Adenosine A2A receptor blockade prevents memory dysfunction caused by β-amyloid peptides but not by scopolamine or MK-801

Cunha, G. M. A., Canas, P. M., Melo, C. S., Hockemeyer, J., Müller, C. E., Oliveira, C. R., & Cunha, R. A. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.013 · Cited by 109 · see citing works

Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and Diabetes Mellitus type-2

Plastino, M., Fava, A., Pirritano, D., Cotronei, P., Sacco, N., Sperlì, T., Spano, A. L., Gallo, D., Mungari, P., Consoli, D., et al. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.09.022 · Cited by 107 · see citing works

Passage of VIP / PACAP / Secretin Family Across the Blood-Brain Barrier: Therapeutic Effects

Doğrukol‐Ak, D., Töre, F., & Tunçel, N. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384934 · Cited by 106 · see citing works

GROα/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for tau hyperphosphorylation—a role in Alzheimer's disease?

Xia, M., & Hyman, B. T. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00463-5 · Cited by 105 · see citing works

Quantitative mRNA analysis of five C-terminal splice variants of the human 5-HT4 receptor in the central nervous system by TaqMan real time RT-PCR

Medhurst, A. D., Lezoualc’h, F., Fischmeister, R., Middlemiss, D. N., & Sanger, G. J. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00095-x · Cited by 105 · see citing works

Alzheimer's disease

Tamminga, C. A., Foster, N. L., Fedio, P., Bird, E. D., & Chase, T. N. (1987) · Neurology · doi:10.1212/wnl.37.1.161 · Cited by 104 · see citing works

Expression of somatostatin receptor subtypes (SSTR1–5) in Alzheimer’s disease brain: An immunohistochemical analysis

Kumar, U. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.04.001 · Cited by 101 · see citing works

Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.

Wall, S. J., Yasuda, R. P., Hory, F., et al. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11072-9 · Cited by 100 · see citing works

Val8-glucagon-like peptide-1 protects against Aβ1–40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats

Wang, X. H., Li, L., Hölscher, C., Pan, Y. F., Chen, X. R., & Qi, J. S. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.028 · Cited by 99 · see citing works

Evidence for a preferential involvement of M1 muscarinic receptors in representational memory

Messer, W. S., Bohnett, M., & Stibbe, J. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90407-z · Cited by 95 · see citing works

Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease

Tsang, S. W. Y., Lai, M. K. P., Kirvell, S. L., Francis, P. T., Esiri, M. M., Hope, T., Chen, C., & Wong, P. T. ‐. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.07.010 · Cited by 92 · see citing works

A GPCR/secretase complex regulates β- and γ-secretase specificity for Aβ production and contributes to AD pathogenesis

Teng, L., Zhao, J., Wang, F., Ma, L., & Pei, G. (2010) · Cell Research · doi:10.1038/cr.2010.3 · Cited by 91 · see citing works

Angiotensin II AT2 Receptor Oligomers Mediate G-protein Dysfunction in an Animal Model of Alzheimer Disease

AbdAlla, S., Lother, H., el Missiry, A., Langer, A., Sergeev, P., el Faramawy, Y., & Quitterer, U. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807746200 · Cited by 89 · see citing works

Angiotensin II Type 2 Receptor-Mediated Apoptosis of Cultured Neurons from Newborn Rat Brain

Shenoy, U. V., Richards, E. M., Huang, X., & Sumners, C. (1999) · Endocrinology · doi:10.1210/endo.140.1.6396 · Cited by 89 · see citing works

Group II Metabotropic Glutamate Receptor Stimulation Triggers Production and Release of Alzheimer's Amyloid β42from Isolated Intact Nerve Terminals

Kim, S. H., Fraser, P. E., Westaway, D. A., George‐Hyslop, P. S., Ehrlich, M. E., & Gandy, S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4717-09.2010 · Cited by 88 · see citing works

Metabolism of Alzheimer beta-amyloid precursor protein: regulation by protein kinase A in intact cells and in a cell-free system.

Xu, H., Sweeney, D. A., Greengard, P., & Gandy, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4081 · Cited by 84 · see citing works

Enkephalin Elevations Contribute to Neuronal and Behavioral Impairments in a Transgenic Mouse Model of Alzheimer's Disease

Meilandt, W. J., Yu, G.-Q., Chin, J., Roberson, E. D., Palop, J. J., Wu, T. Z., Scearce-Levie, K. A., & Mucke, L. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0590-08.2008 · Cited by 84 · see citing works

Metabotropic Glutamate Receptor Subtype mGluR1α Stimulates the Secretion of the Amyloid β‐Protein Precursor Ectodomain

Nitsch, R. M., Deng, A., Wurtman, R. J., & Growdon, J. H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020704.x · Cited by 84 · see citing works

Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's disease

Dournaud, P., Delaère, P., Hauw, J., & Epelbaum, J. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00086-t · Cited by 83 · see citing works

Caffeine Stimulates Amyloid β‐Peptide Release from β‐Amyloid Precursor Protein‐Transfected HEK293 Cells

Querfurth, H. W., Jiang, J., Geiger, J. D., et al. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041580.x · Cited by 80 · see citing works

Improved spatial recognition memory in mice lacking adenosine A2A receptors

Wang, J. H., Yuan, Y., & van den Buuse, M. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.005 · Cited by 78 · see citing works

GPR3 Receptor, a Novel Actor in the Emotional-Like Responses

Valverde, O., Célèrier, E., Baranyi, M., Vanderhaeghen, P., Maldonado, R. J., Sperlágh, B., Vassart, G., & Ledent, C. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004704 · Cited by 78 · see citing works

GLP-1 amplifies insulin signaling by up-regulation of IRβ, IRS-1 and Glut4 in 3T3-L1 adipocytes

Gao, H., Wang, X., Zhang, Z., Yang, Y., Yang, J., Li, X., & Ning, G. (2007) · Endocrine · doi:10.1007/s12020-007-9011-4 · Cited by 77 · see citing works

The serotonin 5-HT6receptor: a viable drug target for treating cognitive deficits in Alzheimer’s disease

Geldenhuys, W. J., & der Schyf, C. J. V. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.51 · Cited by 73 · see citing works

Corticotropin-Releasing Hormone-Mediated Neuroprotection against Oxidative Stress Is Associated with the Increased Release of Non-amyloidogenic Amyloid Precursor Protein and with the Suppression of Nuclear Factor- B

Lezoualc’h, F. (2000) · Molecular Endocrinology · doi:10.1210/me.14.1.147 · Cited by 72 · see citing works

Depression in Alzheimer's disease: The effect of serotonin receptor gene variation

Holmes, C., Arranz, M. J., Collier, D. A., Powell, J. F., & Lovestone, S. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10068 · Cited by 71 · see citing works

5‐HT4 receptor agonists increase sAPPα levels in the cortex and hippocampus of male C57BL/6j mice

Cachard-Chastel, M., Lezoualc’h, F., Dewachter, I., Deloménie, C., Croes, S., Devijver, H., Langlois, M., LEUVEN, F. V., Sicsic, S., & Gardier, A. M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707178 · Cited by 70 · see citing works

Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing β-amyloid precursor protein (APP) with the Swedish double mutation (APP23)

Diez, M., Danner, S., Frey, P., Sommer, B., Staufenbiel, M., Wiederhold, K., & Hökfelt, T. G. M. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.003 · Cited by 69 · see citing works

Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer’s disease

Lee, H., Ogawa, O., Zhu, X., O’Neill, M. J., Petersen, R. B., Castellani, R. J., Ghanbari, H., Perry, G. L., & Smith, M. A. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0820-8 · Cited by 68 · see citing works

Reduction of cerebrospinal fluid amyloid β after systemic administration of M1 muscarinic agonists

Beach, T. G., Walker, D. G., Potter, P. E., Sue, L. I., & Fisher, A. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02484-2 · Cited by 66 · see citing works

CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: Its relationship to severity of dementia and monoamine metabolites

Pomara, N., Singh, R., Deptula, D., et al. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90071-1 · Cited by 65 · see citing works

Pituitary Adenylate Cyclase-Activating Polypeptide Hormone (PACAP) at Very Low Dosages Improves Memory in the Rat

Sacchetti, B., Lorenzini, C. A., Baldi, E., Bucherelli, C., Roberto, M., Tassoni, G., & Brunelli, M. (2001) · Neurobiology of Learning and Memory · doi:10.1006/nlme.2001.4014 · Cited by 63 · see citing works

The Critical Role of Cholinergic Basal Forebrain Neurons in Morphological Change and Memory Encoding: A Hypothesis

Woolf, N. J. (1996) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1996.0068 · Cited by 61 · see citing works

Effect of Subchronic Treatment of Memantine, Galantamine, and Nicotine in the Brain of Tg2576 (APPswe) Transgenic Mice

Lithner, C. U., Svedberg, M. M., Yu, W., Hedberg, M. M., & Nordberg, A. K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098566 · Cited by 59 · see citing works

Polymorphisms at the β2-adrenergic receptor gene influence Alzheimer's disease susceptibility

Yu, J., Tan, L., Ou, J.-R., Zhu, J., Liu, K., Song, J., & Sun, Y. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.019 · Cited by 59 · see citing works

Antagonist of the Amylin Receptor Blocks β-Amyloid Toxicity in Rat Cholinergic Basal Forebrain Neurons

Jhamandas, J. H., & MacTavish, D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1051-04.2004 · Cited by 59 · see citing works

G Protein–Coupled Receptors, Cholinergic Dysfunction, and Aβ Toxicity in Alzheimer’s Disease

Thathiah, A., & Strooper, B. D. (2009) · Science Signaling · doi:10.1126/scisignal.293re8 · Cited by 58 · see citing works

Association analysis of the 5-HT6 receptor polymorphism C267T in Alzheimer's disease

Tsai, S., Liu, H.-C., Liu, T., Wang, Y.-C., & Hong, C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00802-2 · Cited by 57 · see citing works

Tumor Necrosis Factor-α–elicited Stimulation of γ-Secretase Is Mediated by c-Jun N-terminal Kinase-dependent Phosphorylation of Presenilin and Nicastrin

Kuo, L.-H., Hu, M., Hsu, W., Tung, Y.-T., Wang, B., Tsai, W.-W., Yen, C., & Liao, Y.-F. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-09-0987 · Cited by 55 · see citing works

Involvement of formyl-peptide-receptor-like-1 and phospholipase D in the internalization and signal transduction of amyloid beta 1-42 in glial cells

Brandenburg, L., Konrad, M., Wruck, C. J., Koch, T., Pufe, T., & Lucius, R. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.042 · Cited by 53 · see citing works

Effect of a 5-HT2C serotonin agonist, dexnorfenfluramine, on amyloid precursor protein metabolism in guinea pigs

Arjona, A. A., Pooler, A. M., Lee, R. K., & Wurtman, R. J. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03153-0 · Cited by 52 · see citing works

Diminished muscarinic receptor-stimulated [3H]-PIP2 hydrolysis in alzheimer's disease

Ferrari‐DiLeo, G., & Flynn, D. D. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90037-4 · Cited by 51 · see citing works

Memantine treatment decreases levels of secreted Alzheimer's amyloid precursor protein (APP) and amyloid beta (Aβ) peptide in the human neuroblastoma cells

Ray, B., Banerjee, P., Greig, N. H., & Lahiri, D. K. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.016 · Cited by 45 · see citing works

Intracellular Cyclic AMP Inhibits Constitutive and Phorbol Ester‐Stimulated Secretory Cleavage of Amyloid Precursor Protein

Efthimiopoulos, S., Punj, S., Manolopoulos, V. G., Pangalos, M. N., Wang, G. P., Refolo, L. M., & Robakis, N. K. R. K. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67020872.x · Cited by 45 · see citing works

The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival

Lee, H., Zhu, X., Casadesús, G., Pallàs, M., Camins, A., O'Neill, M. J., Nakanishi, S., Perry, G. L., & Smith, M. A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.10.055 · Cited by 43 · see citing works

Dominant Negative AT2 Receptor Oligomers Induce G-protein Arrest and Symptoms of Neurodegeneration

AbdAlla, S., Lother, H., el Missiry, A., Sergeev, P., Langer, A., el Faramawy, Y., & Quitterer, U. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808277200 · Cited by 42 · see citing works

Depletion of CXCR2 inhibits γ-secretase activity and amyloid-β production in a murine model of Alzheimer’s disease

Bakshi, P., Margenthaler, E., Reed, J. M., Crawford, F., & MULLAN, M. J. (2010) · Cytokine · doi:10.1016/j.cyto.2010.10.008 · Cited by 42 · see citing works

Novel Role of CXCR2 in Regulation of γ-Secretase Activity

Bakshi, P., Margenthaler, E., Laporte, V., Crawford, F., & MULLAN, M. J. (2008) · ACS Chemical Biology · doi:10.1021/cb800167a · Cited by 42 · see citing works

Isolation and Chromosomal Localization of a Novel Human G-Protein-Coupled Receptor (GPR3) Expressed Predominantly in the Central Nervous System

Iismaa, T. P., Kiefer, J., LIU, M. L., et al. (1994) · Genomics · doi:10.1006/geno.1994.1635 · Cited by 33 · see citing works

Enhanced generation of Alzheimer’s amyloid‐β following chronic exposure to phorbol ester correlates with differential effects on alpha and epsilon isozymes of protein kinase C

Silva, O. A. B. D. C. E., Rebelo, S., Vieira, S. I., Gandy, S., Silva, E. F. D. C. E., & Greengard, P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05770.x · Cited by 32 · see citing works

MPEP reduces seizure severity in Fmr-1 KO mice over expressing human Abeta.

Westmark, C. J., Westmark, P. R., & Malter, J. S. (2009) · PubMed Central · Cited by 29 · see citing works

Glutamate-stimulated secretion of amyloid precursor protein from cortical rat brain slices

Kirazov, L. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00119-2 · Cited by 28 · see citing works

A1, but not A2A, adenosine receptors modulate electrically stimulated [14C]acetylcholine release from rat cortex.

Broad, R. M., & Fredholm, B. B. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12807-3 · Cited by 25 · see citing works

Distinct Functional Effects of Human 5-HT4 Receptor Isoforms on β-Amyloid Secretion

Robert, S. J., & Lezoualc’h, F. (2008) · Neurodegenerative Diseases · doi:10.1159/000113691 · Cited by 21 · see citing works

The Bad Seed in Alzheimer’s Disease

Fryer, J. D., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.07.002 · Cited by 20 · see citing works

Human metabotropic glutamate receptor 2 couples to the MAP kinase cascade in chinese hamster ovary cells

Phillips, T., Barnes, A., Scott, S., et al. (1998) · Neuroreport · doi:10.1097/00001756-199807130-00034 · Cited by 17 · see citing works

Longitudinal Brain Corticotropin Releasing Factor and Somatostatin in a Transgenic Mouse (TG2576) Model of Alzheimer's Disease

Horgan, J., Miguel-Hidalgo, J. J., Thrasher, M., & Bissette, G. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12201 · Cited by 17 · see citing works

Untitled work

(2000) · doi:10.1002/1531-8249(200012)48:6

Alzheimer's disease

Masters, C. L., Bateman, R., Blennow, K., Rowe, C. C., Sperling, R. A., & Cummings, J. L. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.56 · Cited by 1,853 · see citing works

Microglial Aβ Receptors in Alzheimer’s Disease

Yu, Y., & Ye, R. D. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0101-6 · Cited by 247 · see citing works

APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer’s disease

Vélez, J. I., Lopera, F., Sepulveda-Falla, D., Patel, H. R., Johar, A. S., Chuah, A., Tobón, C., Rivera, D., Villegas, A., Cai, Y., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.177 · Cited by 111 · see citing works

G-protein coupled receptor, PI3K and Rho signaling pathways regulate the cascades of Tau and amyloid-β in Alzheimer’s disease

Desale, S. E., Chidambaram, H., & Chinnathambi, S. (2021) · Molecular Biomedicine · doi:10.1186/s43556-021-00036-1 · Cited by 99 · see citing works

Ascorbic acid ameliorates behavioural deficits and neuropathological alterations in rat model of Alzheimer’s disease

Olajide, O. J., Yawson, E. O., Gbadamosi, I. T., Arogundade, T. T., Lambe, E., Obasi, K., Lawal, I. T., Ibrahim, A., & Ogunrinola, K. Y. (2017) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2017.02.010 · Cited by 79 · see citing works

Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias

van der Westhuizen, E. T., Choy, K. H. C., Valant, C., McKenzie-Nickson, S., Bradley, S. J., Tobin, A. B., Sexton, P. M., & Christopoulos, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.606656 · Cited by 63 · see citing works

Integrated transcriptomic and neuroimaging brain model decodes biological mechanisms in aging and Alzheimer's disease

Adewale, Q., Khan, A. F., Carbonell, F., Iturria-Medina, Y., & Initiative, A. D. N. (2021) · eLife · doi:10.7554/elife.62589 · Cited by 44 · see citing works

Distinct sex-specific DNA methylation differences in Alzheimer’s disease

C. Silva, T., Zhang, W., Young, J. I., Gomez, L., Schmidt, M. A., Varma, A., Chen, X. S., Martin, E. R., & Wang, L. (2022) · Alzheimer's Research &amp; Therapy · doi:10.1186/s13195-022-01070-z · Cited by 33 · see citing works

Beta-amyloid short- and long-term synaptic entanglement

Lanni, C., Fagiani, F., Racchi, M., Preda, S., Pascale, A., Grilli, M., Allegri, N., & Govoni, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.018 · Cited by 29 · see citing works

Mutations modifying sporadic Alzheimer’s disease age of onset

Vélez, J. I., Lopera, F., Patel, H. R., Johar, A. S., Cai, Y., Rivera, D., Tobón, C., Villegas, A., Sepulveda‐Falla, D., Lehmann, S. G., et al. (2016) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32493 · Cited by 19 · see citing works

GPR75: an exciting new target in metabolic syndrome and related disorders

Murtaza, B., Asghar, F., & Patoli, D. (2022) · Biochimie · doi:10.1016/j.biochi.2022.01.005 · Cited by 18 · see citing works

G Protein‐Coupled Receptors

Bockaert, J. (2014) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0000118.pub3 · Cited by 3 · see citing works

A model for the functioning of family 3 GPCRs

Parmentier, M. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02016-3 · Cited by 112 · see citing works

The activation mechanism of class‐C G‐protein coupled receptors

Pin, J., Kniazeff, J., Goudet, C., et al. (2004) · Biology of the Cell · doi:10.1111/j.1768-322x.2004.tb01423.x · Cited by 90 · see citing works

The activation mechanism of class-C G-protein coupled receptors

Pin, J., Kniazeff, J., Goudet, C., Bessis, A. ‐., Liu, J., Galvez, T., Acher, F., Rondard, P., & Prézeau, L. (2004) · Biology of the Cell · doi:10.1016/j.biolcel.2004.03.005 · Cited by 115 · see citing works

Conserved class B GPCR activation by a biased intracellular agonist

Zhao, L., Qian, H., Yuan, Q., Gu, Y., He, X., Shan, H., Li, J., Wang, K., Li, Y., Hu, W., et al. (2023) · Nature · doi:10.1038/s41586-023-06467-w · Cited by 64 · see citing works